Diagnostics Industry Leader Jack Kenny Appointed as Chairman of the Board at Biomerica

• Mr. Kenny has significant executive experience and a proven track record in medical diagnostics and healthcare

• Mr. Kenny most recently served as CEO of Meridian Bioscience where he successfully built and ultimately managed the sale of the company for $1.53 billion

IRVINE, Calif., Jan. 23, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA), a global biomedical company leading the way in innovative gastroenterology solutions, today announced the appointment of Jack Kenny, former CEO and board member of Meridian Bioscience, Inc., to serve as the Chairman of the Board of Directors of Biomerica. Mr. Zack Irani will continue to serve as CEO. Mr. Kenny joined the Biomerica Board of Directors in August 2023 as an independent director.

Most recently Mr. Kenny served as the CEO and executive board member at Meridian Biosciences (formerly traded on Nasdaq under VIVO), which was acquired on January 31, 2023 by SD Biosensor, Inc. and SJL Partners LLC in an all-cash transaction valued at approximately $1.53 billion. Meridian continues to be a leading global provider of diagnostic testing solutions. Meridian’s primary focus was gastroenterology products including H. Pylori where the company was a leading manufacturer of the products in the space.

"I'm excited to work more closely with Zack to help refine the company’s execution strategies for its exciting new inFoods IBS product and the Company’s new HP Detect product, which recently received FDA clearance for sale in the US, and to ensure best-practices corporate governance as we build out Biomerica.”

"Jack's extensive experience as a senior executive in healthcare, clinical laboratories, and medical device industries, spanning over 30 years, is a testament to his capability. Recently, his impactful leadership as CEO at Meridian Bioscience fostered significant growth. He brings not just a wealth of commercial experience but also vital relationships in the medical diagnostic industry," said Zack Irani, CEO of Biomerica. "As we launch inFoods IBS both domestically and internationally, Jack's industry insights will prove invaluable. His strong background in public company governance is especially crucial for us, ensuring robust corporate oversight as our business enters a phase of expansion and growth."